Today, the world's largest health-care product manufacturer, Johnson & Johnson (NYSE:JNJ), reported a higher than expected 2Q profit. Net earnings increased 8% to $3.3 billion, or $1.17 per share, from $3.08 billion, or $1.05 per share, last year. Revenue increased 8.7% to $16.45 billion from $15.1 billion in the year-ago-period. The increases were due to increased sales of its consumer products and medical devices, as well as favorable exchange rates in its overseas transactions.

Contact Chip Brian

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html